Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, W. J.
Right arrow Articles by Chen, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, W. J.
Right arrow Articles by Chen, K. M.

Annals of Surgical Oncology, Vol 2, Issue 3 246-251, Copyright © 1995 by Society of Surgical Oncology


ARTICLES

Breast cancer angiogenesis: a quantitative morphologic and Doppler imaging study

W. J. Lee, J. S. Chu, S. J. Houng, M. F. Chung, S. M. Wang and K. M. Chen
Department of Surgery, National Taiwan University Hospital, Taipei, Republic of China.

BACKGROUND: Tumor growth and metastases require the development of new vessels (angiogenesis). Angiogenesis, assessed by microvessel count using immunocytochemical stain of endothelial cells, has been shown to predict metastases and correlate with early death. Recently developed color Doppler mapping can detect the "tumor flow signals" in breast cancer and help to distinguish it from benign lesions. The question is, does this tumor vascularization assessed by color Doppler mapping correlate with the angiogenesis assessed by immunocytochemistry? METHODS: Eighty-four patients admitted for breast surgery were studied. The final diagnosis was made by pathology for 52 malignancies and 32 benign lesions. The color Doppler mapping of the breast lesion was made preoperatively. The following parameters were assessed: (a) vessel location (peripheral or central); (b) density of color Doppler signals; and (c) maximum systolic velocity. Tumor angiogenesis was assessed by microvessel count under light microscopy using the platelet/endothelial cell adhesion molecule antibodies (CD31) method. The correlation between maximum velocity and microvessel count of breast cancer was examined. The clinical significance of maximum flow velocity of breast cancer with various clinicopathologic factors was assessed. RESULTS: Color signals were detected in 48 cases of 52 malignancies (92%). All tumors demonstrated signals at the periphery of the lesion but in only 13 (27%) were the signals detected within the tumor. Color signals were scored as + + or + + + in 44 (92%) patients. Pulsed wave blood flow was shown in all these 48 tumors, with maximum velocities varying from 4 to 36 cm/s. Among the 32 benign lesions, color signals were detected in 10 (31%) and all were peripheral and scored subjectively as +. Evaluation of these color Doppler mapping parameters shows no significant correlation with microvessel counts using CD31 monoclonal antibodies. However, there was a positive association (p < 0.05) between nodal metastases and higher tumor flow velocity in T1 (< 2 cm) breast tumors but not in larger tumors. CONCLUSION: Although the color Doppler mapping has been shown to be useful in distinguishing benign from malignant breast lesions, the intensity of signal and velocity of flow had no correlation with the extent of angiogenesis of breast cancer. The presence of high-flow tumor signal in early breast carcinoma is significantly associated with the presence of axillary lymph node metastases.


This article has been cited by other articles:


Home page
J Ultrasound MedHome page
W. T. Yang, G. M. K. Tse, P. K. W. Lam, C. Metreweli, and J. Chang
Correlation Between Color Power Doppler Sonographic Measurement of Breast Tumor Vasculature and Immunohistochemical Analysis of Microvessel Density for the Quantitation of Angiogenesis
J. Ultrasound Med., November 1, 2002; 21(11): 1227 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. P. Stevenson, W. P. Collins, F. Farzaneh, K. Hata, and K. Miyazaki
Thymidine Phosphorylase Activity and Prodrug Effects in a Three-Dimensional Model of Angiogenesis : Implications for the Treatment of Ovarian Cancer
Am. J. Pathol., November 1, 1998; 153(5): 1573 - 1578.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the Society of Surgical Oncology.